A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention

10Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Stroke is a leading cause of death and disability worldwide. The importance of lowering blood pressure for reducing the risk of stroke is well established. However, not all the benefits of antihypertensive treatments in stroke can be accounted for by reductions in BP and there may be differences between antihypertensive classes as to which provides optimal protection. Dihydropyridine calcium channel blockers, such as amlodipine, and angiotensin receptor blockers, such as valsartan, represent the two antihypertensive drug classes with the strongest supportive data for the prevention of stroke. Therefore, when combination therapy is required, a combination of these two antihypertensive classes represents a logical approach. © 2009 Wang, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Wang, J. G. (2009). A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention. Vascular Health and Risk Management. Dove Medical Press Ltd. https://doi.org/10.2147/vhrm.s6203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free